Engineering growth factors for regenerative medicine applications

Acta Biomaterialia

Volumn 30, Issue , 2016, Pages 1-12

  Mitchell, Aaron C ^a   Briquez, Priscilla S ^b   Hubbell, Jeffrey A ^b,c,d   Cochran, Jennifer R ^a  

^a Stanford University   (United States)

^b EPFL   (Switzerland)

^c UNIVERSITY OF CHICAGO   (United States)

^d ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

Biomaterials; Controlled release; Drug delivery systems; Extracellular matrix; Growth factors; High throughput screening; Mutagenesis; Protein engineering; Protein library; Regenerative medicine

Indexed keywords

BINDING ENERGY; BIOMATERIALS; CELL ENGINEERING; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; CYTOLOGY; DIAGNOSIS; RECOMBINANT PROTEINS; TARGETED DRUG DELIVERY; TISSUE; TISSUE ENGINEERING;

CONTROLLED RELEASE; DRUG-DELIVERY SYSTEMS; EXTRACELLULAR MATRICES; GROWTH FACTOR; HIGH THROUGHPUT SCREENING; MEDICINE APPLICATION; PROTEIN ENGINEERING; PROTEIN LIBRARY; REGENERATIVE MEDICINE; THERAPEUTIC POTENTIALS;

REGENERATIVE MEDICINE;

CELL SURFACE RECEPTOR; GROWTH FACTOR; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

CELL MIGRATION; CELL RENEWAL; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; HIGH THROUGHPUT SCREENING; HUMAN; INTERNALIZATION; MICROENVIRONMENT; MOLECULAR LIBRARY; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN STABILITY; RECEPTOR BINDING; RECYCLING; REGENERATIVE MEDICINE; REVIEW; TISSUE REGENERATION; ANIMAL; GENETICS; PROCEDURES;

ANIMALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; REGENERATIVE MEDICINE;

EID: 84951569325     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.11.007     Document Type: Review

References (109)

1. C. Mason, and P. Dunnill A brief definition of regenerative medicine Regen. Med. 3 2008 1 5
2. P.S. Briquez, J.A. Hubbell, and M.M. Martino Extracellular matrix-inspired growth factor delivery systems for skin wound healing Adv. Wound Care 150127064149004 2015
3. J. Patterson, M.M. Martino, and J.A. Hubbell Biomimetic materials in tissue engineering Mater. Today 13 2010 14 22
4. R. Goldman Growth factors and chronic wound healing: past, present, and future Adv. Skin Wound Care 17 2004 24 35
5. A.T. Grazul-Bilska, M.L. Johnson, J.J. Bilski, D.A. Redmer, L.P. Reynolds, A. Abdullah, and K.M. Abdullah Wound healing: the role of growth factors Drugs Today 39 2003 787 800
6. M. Atanasova, and A. Whitty Understanding cytokine and growth factor receptor activation mechanisms Crit. Rev. Biochem. Mol. Biol. 47 2012 502 530
7. Drug com, Humatrope (somatropin)-FDA Prescribing Information, Side Effects and Uses, < www.drugs.com/pro/humatrope.html >, 1-17, 2015.
8. U.S. Food and Drug Administration, Safety Warning on Becaplermin in Regranex®, Silver Spring, MD, 1-10, 2008.
9. Medtronic, Infuse® Bone Graft/LT-Cage® Lumbar Tapered Fusion Device, < www.medtronic.com/for-healthcare-professionals/products-therapies/spinal/bone-graft-options/infuse-bone-graft >, 1-2, 2015.
10. Stryker, OP-1/BMP-7-OP-1 Putty for Spinal Fusion, < www.stryker.com/cn/products/Orthobiologicals/Osteoinductive/OP-1/OP-1Putty/127025 >, 1-2, 2015.
11. Medtronic, Bone Graft Surgery, Trauma Surgery, Medtronic INFUSE®, < www.infusebonegraft.com/healthcare-providers/trauma-surgery/index.htm >, 1-3, 2015.
12. Stryker, OP-1/BMP-7 - OP-1 Implant for Fracture Repair, < www.stryker.com/cn/products/Orthobiologicals/Osteoinductive/OP-1/OP-1Implant/020210 >, 1-2, 2015.
13. J. Lee, and M. Blaber Increased functional half-life of fibroblast growth factor-1 by recovering a vestigial disulfide bond J. Proteins Proteomics 2013
14. K. Lee, E.A. Silva, and D.J. Mooney Growth factor delivery-based tissue engineering: general approaches and a review of recent developments J. R. Soc. Interface 8 2011 153 170
15. D. Lipovšek, M. Mena, S.M. Lippow, S. Basu, and B.M. Baynes Library construction for protein engineering Protein Eng. Des. 2009
16. M. Zaccolo, D.M. Williams, D.M. Brown, and E. Gherardi An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues J. Mol. Biol. 255 1996 589 603
17. W.P. Stemmer DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution Proc. Natl. Acad. Sci. U.S.A. 91 1994 10747 10751
18. A.M. Levin, and G.A. Weiss Optimizing the affinity and specificity of proteins with molecular display Mol. BioSyst. 2 2006 49 57
19. S.J. Moore, M.J. Olsen, J.R. Cochran, F.V. Cochran, and D.N. Brown Cell surface display systems for protein engineering Protein Eng. Des. 2009
20. P.A. Barendt, and C.A. Sarkar Cell-free display systems for protein engineering Protein Eng. Des. 2009
21. J.R. Cochran, Y.-S. Kim, S.M. Lippow, B. Rao, and K.D. Wittrup Improved mutants from directed evolution are biased to orthologous substitutions Protein Eng. Des. Sel. 19 2006 245 253
22. H.B. Lowman, S.H. Bass, N. Simpson, and J.A. Wells Selecting high-affinity binding proteins by monovalent phage display Biochemistry 30 1991 10832 10838
23. B.H. Lui, J.R. Cochran, and J.R. Swartz Discovery of improved EGF agonists using a novel in vitro screening platform J. Mol. Biol. 413 2011 406 415
24. W.M. Coco, L.P. Encell, W.E. Levinson, M.J. Crist, A.K. Loomis, L.L. Licato, J.J. Arensdorf, N. Sica, P.T. Pienkos, and D.J. Monticello Growth factor engineering by degenerate homoduplex gene family recombination Nat. Biotechnol. 20 2002 1246 1250
25. C. Souriau, P. Fort, P. Roux, O. Hartley, M.P. Lefranc, and M. Weill A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage Nucleic Acids Res. 25 1997 1585 1590
26. C.C. Reddy, S.K. Niyogi, A. Wells, H.S. Wiley, and D.A. Lauffenburger Engineering epidermal growth factor for enhanced mitogenic potency Nat. Biotechnol. 14 1996 1696 1699
27. T. Arakawa, S.J. Prestrelski, W.C. Kenney, and J.F. Carpenter Factors affecting short-term and long-term stabilities of proteins Adv. Drug Deliv. Rev. 10 1993 1 28
28. C.J. Powers, S.W. McLeskey, and A. Wellstein Fibroblast growth factors, their receptors and signaling Endocr. Relat. Cancer 7 2000 165 197
29. L. Trusolino, A. Bertotti, and P.M. Comoglio MET signalling: principles and functions in development, organ regeneration and cancer Nat. Rev. Mol. Cell Biol. 11 2010 834 848
30. J. Ross, E. Gherardi, N. Mallorqui-Fernandez, M. Bocci, A. Sobkowicz, M. Rees, A. Rowe, S. Ellmerich, I. Massie, J. Soeda, C. Selden, and H. Hodgson Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver Gastroenterology 142 2012 897 906
31. D.S. Jones, P.-C. Tsai, and J.R. Cochran Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists Proc. Natl. Acad. Sci. U.S.A. 108 2011 13035 13040
32. E.V. Shusta, M.C. Kieke, E. Parke, D.M. Kranz, and K.D. Wittrup Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency J. Mol. Biol. 292 1999 949 956
33. C.J. Liu, D.S. Jones II, P.-C. Tsai, A. Venkataramana, and J.R. Cochran An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist FEBS Lett. 588 2014 4831 4837
34. S.B. Sonnenberg, A.A. Rane, C.J. Liu, N. Rao, G. Agmon, S. Suarez, R. Wang, A. Munoz, V. Bajaj, S. Zhang, R. Braden, P.J. Schup-Magoffin, O.L. Kwan, A.N. DeMaria, J.R. Cochran, and K.L. Christman Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction Biomaterials 45 2015 56 63
35. D.J. Craik Joseph Rudinger memorial lecture: discovery and applications of cyclotides J. Pept. Sci. 19 2013 393 407
36. M.W. Popp, S.K. Dougan, T.Y. Chuang, E. Spooner, and H.L. Ploegh Sortase-catalyzed transformations that improve the properties of cytokines Proc. Natl. Acad. Sci. U.S.A. 108 2011 3169 3174
37. F.M. Veronese PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Springer ISBN: 987-3-7643-8678-8
38. J.S. Park, H. Kim, J. Park, S. Yu, D. Kim, J. Lee, H. Oh, K. Baek, and J. Yoon Overproduction of recombinant human hepatocyte growth factor in Chinese hamster ovary cells Protein Expr. Purif. 70 2010 231 235
39. S.J. Stahl, P.T. Wingfield, J.D. Kaufman, L.K. Pannell, V. Cioce, H. Sakata, W.G. Taylor, J.S. Rubin, and D.P. Bottaro Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli Biochem. J. 326 Pt 3 1997 763 772
40. C. Simonneau, B. Leclercq, A. Mougel, E. Adriaenssens, C. Paquet, L. Raibaut, N. Ollivier, H. Drobecq, J. Marcoux, S. Cianférani, D. Tulasne, H. de Jonge, O. Melnyk, and J. Vicogne Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist Chem. Sci. 00 2015 1 12
41. A.L. Cook, P.M. Kirwin, S. Craig, L.J. Bawden, D.R. Green, M.J. Price, S.J. Richardson, A. Fallon, A.H. Drummond, R.M. Edwards, and J.M. Clements Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity Biochem. J. 281 Pt 1 1992 57 65
42. M.S. Kariolis, Y.R. Miao, D.S. Jones, S. Kapur, I.I. Mathews, A.J. Giaccia, and J.R. Cochran An engineered Axl "decoy receptor" effectively silences the Gas6-Axl signaling axis Nat. Chem. Biol. 1-10 2014
43. K. Weiskopf, A.M. Ring, C.C.M. Ho, J.-P. Volkmer, A.M. Levin, A.K. Volkmer, E. Özkan, N.B. Fernhoff, M. van de Rijn, I.L. Weissman, and K.C. Garcia Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies Science 341 2013 88 91
44. K.H. Pearce, B.C. Cunningham, G. Fuh, T. Teeri, and J.A. Wells Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity Biochemistry 38 1999 81 89
45. J.M. Haugh Mathematical model of human growth hormone (hGH)-stimulated cell proliferation explains the efficacy of hGH variants as receptor agonists or antagonists Biotechnol. Prog. 20 2004 1337 1344
46. S. Werner, and R. Grose Regulation of wound healing by growth factors and cytokines Physiol. Rev. 83 2003 835 870
47. A. Buckley, J.M. Davidson, C.D. Kamerath, T.B. Wolt, and S.C. Woodward Sustained release of epidermal growth factor accelerates wound repair Proc. Natl. Acad. Sci. U.S.A. 82 1985 7340 7344
48. G.L. Brown, L. Curtsinger, J.R. Brightwell, D.M. Ackerman, G.R. Tobin, H.C. Polk, C. George-Nascimento, P. Valenzuela, and G.S. Schultz Enhancement of epidermal regeneration by biosynthetic epidermal growth factor J. Exp. Med. 163 1986 1319 1324
49. J.L. Lahti, B.H. Lui, S.E. Beck, S.S. Lee, D.P. Ly, M.T. Longaker, G.P. Yang, and J.R. Cochran Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation FEBS Lett. 585 2011 1135 1139
50. A.E. Lenferink, E.J. van Zoelen, M.J. van Vugt, S. Grothe, W. van Rotterdam, M.L. van De Poll, and M.D. O'Connor-McCourt Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants J. Biol. Chem. 275 2000 26748 26753
51. M.C. Jewett, and J.R. Swartz Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis Biotechnol. Bioeng. 86 2004 19 26
52. R. Ebner, and R. Derynck Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes Cell Regul. 2 1991 599 612
53. H.A.J. Alwan, E.J.J. van Zoelen, and J.E.M. van Leeuwen Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination J. Biol. Chem. 278 2003 35781 35790
54. A.R. French, D.K. Tadaki, S.K. Niyogi, and D.A. Lauffenburger Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction J. Biol. Chem. 270 1995 4334 4340
55. C.A. Sarkar, K. Lowenhaupt, T. Horan, T.C. Boone, B. Tidor, and D.A. Lauffenburger Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching" Nat. Biotechnol. 20 2002 908 913
56. Y. Ito Covalently immobilized biosignal molecule materials for tissue engineering Soft Matter 4 2008 46 56
57. K. Ogiwara, M. Nagaoka, C.-S. Cho, and T. Akaike Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc Biotechnol. Lett. 27 2005 1633 1637
58. E. Schönherr, and H. Hausser Extracellular matrix and cytokines: a functional unit J. Immunol. Res. 2000 10.1155/2000/31748
59. R.O. Hynes The extracellular matrix: not just pretty fibrils Science 326 2009 1216 1219
60. G.S. Schultz, G. Ladwig, and A. Wysocki Extracellular matrix: review of its roles in acute and chronic wounds World Wide Wounds 2005
61. S.H. Kim, J. Turnbull, and S. Guimond Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor J. Endocrinol. 209 2011 139 151
62. A.G. Arroyo, and M.L. Iruela-Arispe Extracellular matrix, inflammation, and the angiogenic response Cardiovasc. Res. 86 2010 226 235
63. G.S. Schultz, and A. Wysocki Interactions between extracellular matrix and growth factors in wound healing Wound Repair Regen. 17 2009 153 162
64. J.A. Hubbell Matrix-bound growth factors in tissue repair Swiss Med. Wkly. 1-6 2006
65. L. Macri, D. Silverstein, and R.A.F. Clark Growth factor binding to the pericellular matrix and its importance in tissue engineering Adv. Drug Deliv. Rev. 59 2007 1366 1381
66. M. Bernfield, M. Götte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, and M. Zako Functions of cell surface heparan sulfate proteoglycans Annu. Rev. Biochem. 68 1999 729 777
67. R. Raman, G. Venkataraman, S. Ernst, V. Sasisekharan, and R. Sasisekharan Structural specificity of heparin binding in the fibroblast growth factor family of proteins Proc. Natl. Acad. Sci. U.S.A. 100 2003 2357 2362
68. D.M. Ornitz, A. Yayon, J.G. Flanagan, C.M. Svahn, E. Levi, and P. Leder Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells Mol. Cell. Biol. 12 1992 240 247
69. S. Ashikari-Hada, H. Habuchi, Y. Kariya, N. Itoh, A.H. Reddi, and K. Kimata Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library J. Biol. Chem. 279 2004 12346 12354
70. M.M. Martino, P.S. Briquez, E. Guc, F. Tortelli, W.W. Kilarski, S. Metzger, J.J. Rice, G.A. Kuhn, R. Muller, M.A. Swartz, and J.A. Hubbell Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing Science 343 2014 885 888
71. Z. Poltorak, T. Cohen, R. Sivan, Y. Kandelis, G. Spira, I. Vlodavsky, E. Keshet, and G. Neufeld VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix J. Biol. Chem. 272 1997 7151 7158
72. M.M. Martino, and J.A. Hubbell The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain FASEB J. 24 2010 4711 4721
73. M.M. Martino, P.S. Briquez, A. Ranga, M.P. Lutolf, and J.A. Hubbell Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix Proc. Natl. Acad. Sci. U.S.A. 110 2013 4563 4568
74. L. De Laporte, J.J. Rice, F. Tortelli, and J.A. Hubbell Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain PLoS One 8 2013 e62076 (A.J. Engler, Ed.)
75. Z. Upton, L. Cuttle, A. Noble, M. Kempf, G. Topping, J. Malda, Y. Xie, J. Mill, D.G. Harkin, O. Kravchuk, D.I. Leavesley, and R.M. Kimble Vitronectin: growth factor complexes hold potential as a wound therapy approach J. Invest. Dermatol. 128 2008 1535 1544
76. D. Schuppan, M. Schmid, R. Somasundaram, R. Ackermann, M. Ruehl, T. Nakamura, and E.O. Riecken Collagens in the liver extracellular matrix bind hepatocyte growth factor YGAST 114 1998 139 152
77. E.S. Wijelath, S. Rahman, M. Namekata, J. Murray, T. Nishimura, Z. Mostafavi-Pour, Y. Patel, Y. Suda, M.J. Humphries, and M. Sobel Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism Circ. Res. 99 2006 853 860
78. M.M. Martino, F. Tortelli, M. Mochizuki, S. Traub, D. Ben-David, G.A. Kuhn, R. Müller, E. Livne, S.A. Eming, and J.A. Hubbell Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing Sci. Transl. Med. 3 2011 100ra89
79. K.M. Lorentz, L. Yang, P. Frey, and J.A. Hubbell Engineered insulin-like growth factor-1 for improved smooth muscle regeneration Biomaterials 33 2012 494 503
80. N. Ferrara Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action Mol. Biol. Cell 21 2010 687 690
81. N.E. Epstein Complications due to the use of BMP/INFUSE in spine surgery: the evidence continues to mount Surg. Neurol. Int. 4 2013 343
82. M.M. Martino, P.S. Briquez, K. Maruyama, and J.A. Hubbell Extracellular matrix-inspired growth factor delivery systems for bone regeneration Adv. Drug Deliv. Rev. 1-12 2015
83. T.J. Keane, and S.F. Badylak Biomaterials for tissue engineering applications Semin. Pediatr. Surg. 23 2014 112 118
84. J.J. Song, and H.C. Ott Organ engineering based on decellularized matrix scaffolds Trends Mol. Med. 17 2011 424 432
85. T.W. Gilbert, T.L. Sellaro, and S.F. Badylak Decellularization of tissues and organs Biomaterials 27 2006 3675 3683
86. J.E. Reing, B.N. Brown, K.A. Daly, J.M. Freund, T.W. Gilbert, S.X. Hsiong, A. Huber, K.E. Kullas, S. Tottey, and M.T. Wolf The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds Biomaterials 31 2010 8626 8633
87. S.B. Seif-Naraghi, D. Horn, P.J. Schup-Magoffin, and K.L. Christman Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor Acta Biomater. 8 2012 3695 3703
88. O.O. Ige, L.E. Umoru, and S. Aribo Natural products: a minefield of biomaterials ISRN Mater. Sci. 2012 2012 1 20
89. A. Sahni, O.D. Altland, and C.W. Francis FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth J. Thromb. Haemost. 1 2003 1304 1310
90. A. Sahni, and C.W. Francis Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation Blood 96 2000 3772 3778
91. A.H. Zisch, M.P. Lutolf, and J.A. Hubbell Biopolymeric delivery matrices for angiogenic growth factors Cardiovasc. Pathol. 12 2003 295 310
92. S. Young, M. Wong, Y. Tabata, and A.G. Mikos Gelatin as a delivery vehicle for the controlled release of bioactive molecules J. Control. Release 109 2005 256 274
93. H. Igai, S.S. Chang, M. Gotoh, Y. Yamamoto, N. Misaki, T. Okamoto, M. Yamamoto, Y. Tabata, and H. Yokomise Regeneration of canine tracheal cartilage by slow release of basic fibroblast growth factor from gelatin sponge ASAIO J. 52 2006 86 91
94. M. Yamamoto, Y. Takahashi, and Y. Tabata Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel Tissue Eng. 12 2006 1305 1311
95. S.E. Sakiyama-Elbert, and J.A. Hubbell Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix J. Control. Release 2000
96. H.S. Yang, W.-G. La, Y.-M. Cho, W. Shin, G.-D. Yeo, and B.-S. Kim Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration Exp. Mol. Med. 44 2012 350
97. A. Baker, H. Kim, J.L. Semple, D. Dumont, M. Shoichet, D. Tobbia, and M. Johnston Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy Breast Cancer Res. 12 2010 R70
98. Z. Upton, H.J. Wallace, G.K. Shooter, D.R. van Lonkhuyzen, S. Yeoh Ellerton, E.A. Rayment, J.M. Fleming, D. Broszczak, D. Queen, R.G. Sibbald, D.I. Leavesley, and M.C. Stacey Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds Int. Wound J. 8 2011 522 532
99. Y. Xie, Z. Upton, S. Richards, S.C. Rizzi, and D.I. Leavesley Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin: growth factor complexes in wound healing applications J. Control. Release 153 2011 225 232
100. D.G. Belair, N.N. Le, and W.L. Murphy Design of growth factor sequestering biomaterials Chem. Commun. 50 2014 15651 15668
101. M. Hajimiri, S. Shahverdi, G. Kamalinia, and R. Dinarvand Growth factor conjugation: strategies and applications J. Biomed. Mater. Res. 103 2014 819 838
102. L.L.Y. Chiu, and M. Radisic Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues Biomaterials 31 2010 226 241
103. M. Ehrbar, V.G. Djonov, C. Schnell, S.A. Tschanz, G. Martiny-Baron, U. Schenk, J. Wood, P.H. Burri, J.A. Hubbell, and A.H. Zisch Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth Circ. Res. 94 2004 1124 1132
104. M. Ehrbar, S.C. Rizzi, R. Hlushchuk, V. Djonov, A.H. Zisch, J.A. Hubbell, F.E. Weber, and M.P. Lutolf Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering Biomaterials 28 2007 3856 3866
105. M. Ehrbar, A. Metters, P. Zammaretti, J.A. Hubbell, and A.H. Zisch Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity J. Control. Release 101 2005 93 109
106. R.E. Miller, A.J. Grodzinsky, K. Cummings, A.H.K. Plaas, A.A. Cole, R.T. Lee, and P. Patwari Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate Arthritis Rheum. 62 2010 3686 3694
107. W. Sun, H. Lin, B. Chen, W. Zhao, Y. Zhao, Z. Xiao, and J. Dai Collagen scaffolds loaded with collagen-binding NGF-beta accelerate ulcer healing J. Biomed. Mater. Res. 92 2010 887 895
108. Q. Han, W. Sun, H. Lin, W. Zhao, Y. Gao, Y. Zhao, B. Chen, Z. Xiao, W. Hu, Y. Li, B. Yang, and J. Dai Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats Tissue Eng. Part A 15 2009 2927 2935
109. W. Sun, C. Sun, H. Lin, H. Zhao, J. Wang, H. Ma, B. Chen, Z. Xiao, and J. Dai The effect of collagen-binding NGF-beta; on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model Biomaterials 30 2009 4649 4656